The SLC1A3 gene helps clear the brain chemical glutamate from around nerve cells, which supports steady signaling and protects brain tissue. This gene plays an important role in how brain cells and support cells keep messages from getting too strong. If it does not work properly, glutamate can build up, and some people may have episodes of poor coordination, unusual movements, seizures, or migraine with aura. Certain variants are linked to a rare inherited condition that causes brief attacks of imbalance.
What is a gene?
A gene is a section of DNA that gives your cells instructions for making molecules or regulating processes throughout the body. Some genes carry the information needed to make proteins, the parts of cells that do much of the work. Others mainly direct when certain processes happen, where they happen, and how active they are. Together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medications. To explore this topic in more detail, you can learn more in the LearnHub.
Overview
SLC1A3Gene function
What if the gene works
The SLC1A3 gene helps brain support cells clear glutamate, a nerve signaling chemical, from spaces between nerve cells. This helps keep brain signals balanced and protects cells from overstimulation.
Risk
What if the gene does not work
Variants in the SLC1A3 gene can disrupt brain glutamate clearing, causing episodic ataxia with attacks of poor balance and, in some people, seizures or developmental differences. Milder to more severe variants may influence onset and symptom range.
Treatment
What does that mean for your treatment
No SLC1A3-specific treatment or drug-selection approach is currently established for people with a pathogenic variant in the SLC1A3 gene. The SLC1A3 gene is being studied in early-stage research as a possible biomarker and drug target in some neurologic conditions and certain cancers.
Conditions associated with SLC1A3
Gene function
What if the gene works
In the brain and retina, the SLC1A3 gene helps keep nerve signaling balanced by moving glutamate out of the space between cells. Glutamate is a main chemical messenger, so clearing it at the right time helps signals stay precise. Understanding how the SLC1A3 gene works can make it easier to see how support cells help steady day to day communication.
The SLC1A3 gene helps support cells take glutamate away from the space around nerve cells after a message is sent. This keeps signals from lasting longer than they should and helps communication stay precise.
By clearing glutamate promptly, this gene helps nerve cells communicate with better timing and control. It supports normal excitatory signaling, which is the type of signaling that helps brain cells pass messages.
Cells use the protein made from the SLC1A3 gene to take glutamate back up so it can be processed and reused. This helps the brain manage an important chemical messenger during everyday activity.
What is a variant?
A genetic variant is a minor difference in the DNA sequence of a gene. These differences are common and are part of normal human diversity, including variations in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC1A3 gene can alter the transporter’s shape, keep it from reaching the cell surface, or change how well it moves the brain signaling chemical glutamate. This is how SLC1A3 gene variants affect protein function at the cellular level. Some changes leave partial activity, while more severe variants can greatly reduce transport or interfere with the working protein made from the other gene copy. Stronger disruption is often linked to earlier or more marked neurologic features.
How variants are linked to conditions
Pathogenic variants in the SLC1A3 gene are best known for causing episodic ataxia type 6, so discussions of SLC1A3 gene variants and episodic ataxia usually focus on this condition. People may have repeated spells of poor balance, dizziness, or trouble coordinating movement, and some also have seizures or migraine. Some variants in the SLC1A3 gene have also been linked to developmental and epileptic encephalopathy, with seizures and developmental differences beginning early in life.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors play a role. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SLC1A3 gene. Risk can vary by the exact gene change and the condition involved, so people with concerns about their personal or family risk should speak with a doctor or genetic counselor.
Inheritance of SLC1A3 variants
For the main condition linked to this gene, the SLC1A3 inheritance pattern is autosomal dominant. This means a person with a disease-causing variant in one copy of the SLC1A3 gene can pass it on to a child, and each pregnancy carries a 50% chance of inheriting that variant. In some families the variant is inherited from an affected parent, while in others it can appear for the first time as a new de novo variant. Sons and daughters are affected and can inherit it equally.
What does my SLC1A3 result mean for my family?
For the recognized SLC1A3-related condition that causes repeated episodes of balance problems, the pattern is usually dominant. That means close relatives such as a parent, brother, sister, or child may also carry the same gene change and may have symptoms or a family history of similar spells, migraine, or coordination problems. In some families, the change appears for the first time in one person, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
To look for variants, genetic testing of the SLC1A3 gene usually uses DNA from a blood sample or saliva sample. A lab reads the gene’s code to check for changes that may help explain symptoms or confirm a suspected inherited condition. Results may show a known variant, no relevant variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Consider genetic testing for the SLC1A3 gene if there are repeated unexplained episodes of balance trouble, unsteady walking, dizziness, or migraine-like attacks, especially when they start in childhood or run in the family. Testing may also be considered when these symptoms come with seizures, developmental delays, or learning problems.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it explains depends on both the condition and the kind of variant present. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, it can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it into tissues, or responds to its effects. This helps explain why the same medication works well for one person, works less well for another, or causes more side effects in some people. These differences are common and are one part of the bigger picture, along with age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect their response to medications. It looks at connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medications, genes influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more individualized. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the SLC1A3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so any concerns about symptoms, side effects, or how medicines may affect you are best discussed with your doctor.
History
Researchers identified the SLC1A3 gene in the 1990s during a period of rapid progress in brain genetics, when several glutamate transporter genes were first being cloned and mapped. Initially understood only through visible traits, later recognized as tied to a specific gene, this work helped connect earlier physiology studies with a defined stretch of DNA. SLC1A3 became better known in neuroscience after it was linked to the transporter called EAAT1, also known as GLAST in older research papers. From these first observations, research expanded steadily. In the 2000s, rare variants in the SLC1A3 gene were reported in some families with episodic ataxia, which brought the gene into clinical genetics as well as laboratory research. Since then, its history has been shaped mainly by steady scientific work rather than public headlines.